Recombinant Lactic Acid Bacteria as Potential Oral Vaccine Vectors against Multidrug-Resistant Acinetobacter Baumannii
Journal of Pioneering Medical Sciences · 05.11.2026 · 15 (10) · 82-94
DOI: 10.47310/jpms2026151008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pioneering Medical Sciences, online erschienen am 05.11.2026. Verfasst von Hadeel M. Khalaf und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Multidrug-resistant Acinetobacter baumannii (MDR-AB) is an important healthcare-associated pathogen for which preventive vaccine strategies remain under investigation. Recombinant lactic acid bacteria (LAB) are being explored as vectors for oral antigen delivery, but their relevance to MDR-AB requires careful distinction between direct and indirect evidence. This scoping review summarized English-language publications retrieved from PubMed, Scopus, and Google Scholar for the period January 2018 to December 2024. Out of the 213 articles found initially, 46 articles were included in the review and classified into three themes: LAB strain (n = 23), recombinant oral vaccines (n = 7), and A. baumannii antigen and vaccine (n = 16). LABs contributed to knowledge about strain properties, vector development, and mucosal antigen delivery, which included vaccines against bacteria other than A. baumannii. On the other hand, studies of A. baumannii have analyzed antigens such as outer membrane proteins, adhesions, and outer membrane vesicles mainly through the use of non-laboratory-adapted (non-LAB) vaccination methods. These two strands of research provide complementary evidence for the development of an oral recombinant LAB vaccine for A. baumannii but cannot demonstrate the direct efficacy of the vaccine. Research challenges are involved in antigen choice, stability of the construct, antigen expression, immunogenicity at both mucosal and systemic level, standardization of the challenge method and safety study. Therefore, while recombinant lactic acid bacteria (LABs) represent a promising approach to oral vaccines, their protective efficacy against MDR-AB is not yet proven.
Zitieren
APA
Khalaf, H. M., Ismail, N. I., Owaif, H. A. A., Raypah, M. E., & Yaakop, A. S. (2026). Recombinant Lactic Acid Bacteria as Potential Oral Vaccine Vectors against Multidrug-Resistant Acinetobacter Baumannii. Journal of Pioneering Medical Sciences, 15(10), 82-94. https://doi.org/10.47310/jpms2026151008
Vancouver
Khalaf HM, Ismail NI, Owaif HAA, Raypah ME, Yaakop AS. Recombinant Lactic Acid Bacteria as Potential Oral Vaccine Vectors against Multidrug-Resistant Acinetobacter Baumannii. Journal of Pioneering Medical Sciences. 2026;15(10):82-94. doi:10.47310/jpms2026151008
BibTeX
@article{Khalaf2026,
author = {Khalaf, Hadeel M. and Ismail, Nurul Izza and Owaif, Hasan A. Aal and Raypah, Muna E. and Yaakop, Amira Suriaty},
title = {Recombinant Lactic Acid Bacteria as Potential Oral Vaccine Vectors against Multidrug-Resistant Acinetobacter Baumannii},
journal = {Journal of Pioneering Medical Sciences},
year = {2026},
volume = {15},
number = {10},
pages = {82--94},
doi = {10.47310/jpms2026151008}
}
EUVIMED